₹1,846.35-5.55 (-0.30%)
04:01 PM, 8-Jan-2025₹1,849.80-0.25 (-0.01%)
03:53 PM, 8-Jan-2025BSE : 543245
NSE : GLAND
Sector : Health care
ISIN Code : INE068V01023
Last Updated: 08-Jan-2025 | 04:01 PM IST
Market Cap (₹ Cr) | 30,428 |
Traded Value (₹ Cr) | 2.01 |
Volume (Shares) | 10,877 |
Face Value (₹) | 1 |
52-Week High (₹) | 2,220.95 |
52-Week High Date | 06-Aug-2024 |
52-Week Low (₹) | 1,590.00 |
52-Week Low Date | 24-Oct-2024 |
All Time High (₹) | 4,350.00 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 861.50 |
All Time Low Date | 22-May-2023 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 30,485 |
EPS - TTM (₹) [C] | 41.98 |
P/E Ratio (X) [C] | 44.06 |
Face Value (₹) | 1 |
Latest Dividend (%) | 2,000.00 |
Latest Dividend Date | 16-Aug-2024 |
Dividend Yield (%) | 1.08 |
Book Value Share (₹) [C] | 533.41 |
P/B Ratio (₹) [C] | 3.47 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Nippon India Growth Fund - (G) | 498.22 | 28,00,000 | 1.41 |
Nippon India Growth Fund - (IDCW) | 498.22 | 28,00,000 | 1.41 |
Nippon India Growth Fund - (Bonus) | 498.22 | 28,00,000 | 1.41 |
Nippon India Growth Fund - Inst (IDCW) | 498.22 | 28,00,000 | 1.41 |
Nippon India Growth Fund - Direct (Bonus) | 498.22 | 28,00,000 | 1.41 |
Nippon India Growth Fund - Direct (G) | 498.22 | 28,00,000 | 1.41 |
Nippon India Growth Fund - Direct (IDCW) | 498.22 | 28,00,000 | 1.41 |
Nippon India Small Cap Fund (G) | 316.79 | 17,80,371 | 0.51 |
Nippon India Small Cap Fund (IDCW) | 316.79 | 17,80,371 | 0.51 |
Nippon India Small Cap Fund (B) | 316.79 | 17,80,371 | 0.51 |
Load more
Today's Low/High (₹) | 1,836.15 1,912.90 |
Week Low/High (₹) | 1,762.80 1,964.00 |
Month Low/High (₹) | 1,725.00 1,964.00 |
Year Low/High (₹) | 1,585.70 2,221.00 |
All time Low/High (₹) | 861.50 4,350.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 2.21% | 2.19% | -0.46 | -0.23% |
1 Month | 1.97% | 2.02% | -4.36 | -4.01% |
3 Month | 8.84% | 8.83% | -4.27 | -5.29% |
6 Month | -1.86% | -1.88% | -2.27 | -2.60% |
1 Year | -4.12% | -4.18% | 9.52 | 10.11% |
3 Year | -52.74% | -52.75% | 30.80 | 32.99% |
Chairman & Independent Directo : Yiu Kwan Stanley Lau
Managing Director & CEO : SRINIVAS SADU
Non-Exec & Non-Independent Dir : UDO JAHANNES VETTER
Independent Director : C S N Murthy
Independent Director : ESSAJI GOOLAM VAHANVATI
Independent Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Non Executive Director : Wenjie Zhang
Additional Director : Wei Huang
Registered Office: Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal,Hyderabad,Telangana-500043 Ph: 91-40-30510999
1. What's the Gland Pharma Ltd share price today?
Gland Pharma Ltd share price was Rs 1,846.35 at 04:01 PM IST on 8th Jan 2025. Gland Pharma Ltd share price was down by 0.30% from the previous closing price of Rs 1,851.90. Gland Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Gland Pharma Ltd stock?
The performance of the Gland Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Gland Pharma Ltd?
Gland Pharma Ltd has a market capitalisation of Rs 30,428 crore.
4. What is Gland Pharma Ltd's 52-week high/low share price?
The Gland Pharma Ltd’s 52-week high share price is Rs 2,220.95 and 52-week low share price is Rs 1,590.00.
5. Is the Gland Pharma Ltd profitable?
On a consolidated basis, Gland Pharma Ltd reported a profit of Rs 281.71 crore on a total income of Rs 1,120.79 crore for the quarter ended 2024. For the year ended Sep 2024, Gland Pharma Ltd had posted a profit of Rs 163.53 crore on a total income of Rs 1,465.49 crore.
6. Which are Gland Pharma Ltd’s peers in the Health care sector?
Gland Pharma Ltd’s top 5 peers in the Health care sector are Ajanta Pharma, Laurus Labs, Piramal Pharma, Gland Pharma, J B Chemicals &, Suven Pharma, Emcure Pharma.
7. Who owns how much in Gland Pharma Ltd?
Key changes to the Gland Pharma Ltd shareholding are as follows: